Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating trial-Reference-Cited by-同舟云学术

Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating trial

Published:2007-12 Issue:12 Volume:56 Page:4142-4150
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Dall'Era Maria,Chakravarty Eliza,Wallace Daniel,Genovese Mark,Weisman Michael,Kavanaugh Arthur,Kalunian Kenneth,Dhar Patricia,Vincent Emmanuelle,Pena-Rossi Claudia,Wofsy David,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference28 articles.

1. B cells move to centre stage: novel opportunities for autoimmune disease treatment;Browning;Nat Rev Drug Discov,2006

2. An open study of B lymphocyte depletion in systemic lupus erythematosus;Leandro;Arthritis Rheum,2002

3. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab;Looney;Arthritis Rheum,2004

4. B cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients;Leandro;Rheumatology (Oxford),2005

5. Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus;Dorner;Arthritis Res Ther,2006

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis;Human Vaccines & Immunotherapeutics;2024-08-16

2. Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development;Expert Opinion on Investigational Drugs;2024-07-09

3. Exploring the depths of IgG4: insights into autoimmunity and novel treatments;Frontiers in Immunology;2024-04-18

4. B cells in multiple sclerosis;Mechanisms of Disease Pathogenesis in Multiple Sclerosis;2024

5. Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies;ACR Open Rheumatology;2023-09-14